Dr. Christopher M. Kramer, MD

Dr. Kramer practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Kramer's NPI, 1528137148, was assigned on November 7, 2006. Dr. Kramer graduated from University of California, San Francisco School of Medicine in 1986. Dr. Kramer holds Virginia license 0101222224.

Dr. Kramer's primary practice is University of Virginia Physicians Group, at 500 Ray C Hunt Dr, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Kramer's primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Kramer is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Kramer to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kramer practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kramer's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kramer is licensed in Virginia.

CMS data shows 884 Medicare services from Dr. Kramer across 13 procedure codes in 2024, for 704 Medicare patients. Medicare paid $42,073 for them.

CMS counts 704 Medicare patients who saw Dr. Kramer in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kramer's median patient age at 63, with 44% women.

In 2024, Dr. Kramer wrote 482 Medicare Part D claims for 79 patients. 79% of them were for generic drugs. CMS names the drug for 406 of them, across 13 drugs with 11 or more claims each, at $193,250 in total drug cost. In 2023, CMS named 298 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kramer for performance year 2024, reported through an alternative payment model (APM). Dr. Kramer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kramer as offering telehealth.

Dmand AI links 137 papers to Dr. Kramer, published from 2013 to 2025. 2019 was the busiest year, with 17. The most frequent topics are Magnetic Resonance Imaging, Cardiomyopathy, Hypertrophic and Predictive Value of Tests. Dr. Kramer has published most often in JACC Cardiovasc Imaging. Dr. Kramer's most frequent co-authors are Michael Salerno, MD, PhD, Raymond Y. Kwong, MD and Milind Y. Desai, MD.

Dmand AI links Dr. Kramer to 1 clinical trial. Conditions studied include Obesity and Overnutrition. Open Payments lists research payments to Dr. Kramer that name 2 trials.

CMS Open Payments shows 99 general payments to Dr. Kramer from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Bristol-Myers Squibb Company paid the most, $52,269. It also lists 5 research payments totaling $184,857 from 2022 to 2025, naming 2 clinical trials.

Dr. Kramer graduated from University of California, San Francisco School of Medicine in 1986.